Cargando…
Drug-drug interaction with oral antivirals for early treatment of COVID-19 – Authors’ reply
Autor principal: | Larsen, Carsten Schade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715456/ https://www.ncbi.nlm.nih.gov/pubmed/36470503 http://dx.doi.org/10.1016/j.ijid.2022.11.038 |
Ejemplares similares
-
Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023) -
Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19
por: Larsen, Carsten Schade
Publicado: (2022) -
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
por: Bartoletti, Michele, et al.
Publicado: (2022) -
‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ – Author’s reply
por: Wolkewitz, Martin, et al.
Publicado: (2021) -
‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)